エバー医師 脳神経クリニック
| 中国 | トルコ | オーストリア | |
| 脳深部刺激療法 | から $34,500 | から $23,000 | から $45,000 |
| 幹細胞治療 | から $22,500 | から $25,000 | から $35,000 |
| パーキンソン病の薬物療法 | から $3,800 | から $1,000 | から $2,000 |
| MRガイド下集束超音波治療 | から $15,500 | から $10,000 | から $16,000 |
| 人工多能性幹細胞療法 | から $32,000 | - | - |
Professor ZHENG Wei Hong is Director of the Department of Neurology and the discipline leader. He previously served as Director of Neurology at Xiamen University Affiliated Zhongshan Hospital. He is a Professor at Xiamen University and a master's supervisor.
His clinical focus includes etiological investigation, prevention, and treatment of cerebral infarction and cerebral hemorrhage. He also diagnoses and treats complex neurological diseases, including epilepsy, neuroimmunological and neuromuscular disorders (myasthenia gravis, multiple sclerosis), and Parkinson's disease.
Appointments: He serves as a committee member of the Neuroimmunology Group (Chinese Medical Association Neurology Branch), the Immunology Branch (Chinese Stroke Association), Neurorestoration (Chinese Medical Doctor Association), and Cognitive Impairment (Chinese Geriatrics Society). He is on the Standing Committee of the Expert Committee of Stroke Screening and Prevention Engineering Base Hospitals (Ministry of Health). He is a member of the Neurology Expert Group, Fujian Provincial Medical Quality Control Center for Stroke and Epilepsy. He is Standing Director of the Fujian Anti‑Epilepsy Association. He is Deputy Group Leader of the Epilepsy and Electroencephalography Group (Fujian Medical Association Neurology Branch). He is Deputy Chairperson of the 1st Committee, Neurology Physicians Branch (Fujian Medical Doctor Association). He is a Standing Committee Member (5th–7th) of the Neurology Branch (Fujian Medical Association). He is Deputy Chairperson of the Neurology Professional Committee (Xiamen Medical Association).
Primary Parkinson's treatment in China integrates Western pharmacological standards, advanced neurosurgery, and Traditional Chinese Medicine (TCM). Specialized centers offer Deep Brain Stimulation (DBS) and Magnetic Resonance-guided Focused Ultrasound (MRgFUS). Some institutions also conduct research into induced pluripotent stem cell therapies for neurorestoration.
Bookimed Expert Insight: China's Class A Level III hospitals, like Yanda International, offer a rare structural advantage by combining JCI-accredited neurology departments with ancient Qihuang medicinal research. This allows patients to access high-tech interventions like DBS alongside highly regulated TCM protocols. While general clinics exist, choosing facilities with academic ties to institutions like Peking University ensures a higher standard of supervised, multi-modal care.
Patient Consensus: Patients note that standard medications and DBS are widely accessible and affordable. Many advise caution regarding unproven stem cell `cures,` recommending that newcomers stick to established hospitals and verify treatment claims through long-term tracking.
Stem cell therapy for Parkinson disease in China remains experimental. Clinical trials show up to 80% efficiency in converting stem cells into functional dopamine neurons. Most advanced neural transplants are restricted to competitive trials in Beijing and Shanghai. They are not yet standard treatments.
Bookimed Expert Insight: While experimental stem cell research dominates headlines, established facilities like Yanda International Hospital serve 2,500,000 patients annually using JCI-accredited protocols. Our data shows that top Chinese neurosurgeons, such as Dr. Shao Ming, often hold multiple fellowships from Harvard or UCLA. Patients seeking movement disorder treatments should prioritize these high-volume, accredited hospitals over smaller, unproven clinics offering experimental injections.
Patient Consensus: Patients note that while medical visas for China are accessible, many stem cell treatments currently offered through tourism are considered unproven. International communities strongly recommend choosing established therapies like Deep Brain Stimulation or waiting for peer-reviewed Phase III trial results.
China integrates traditional Chinese medicine with modern neurosurgery and cell-based therapies. Treatment often begins at earlier disease stages compared to Western protocols. High-volume centers perform deep brain stimulation and magnetic resonance-guided focused ultrasound surgery. This proactive approach aims to balance body systems while managing motor symptoms.
Bookimed Expert Insight: Clinical data from Yanda International Hospital shows how China manages massive patient volumes. This Joint Commission International-accredited facility serves 2,500,000 patients annually. Such high volume allows Chinese specialists to gain surgical experience much faster than Western peers. For example, Dr. Zheng Wei Hong manages complex movement disorders within a system performing 9,000 operations yearly. This experience often leads to shorter wait times for advanced procedures like stereotactic electrode implantation.
Patient Consensus: Patients often notice that Chinese clinics offer intensive cell-based therapies and focused ultrasound much sooner than Western doctors. They highlight the importance of choosing high-volume, accredited hospitals to ensure safety and better follow-up care.
Tai Chi measurably slows Parkinson's progression by improving motor and non-motor functions. Clinical research confirms it reduces medication dependency and enhances brain connectivity. Regular practice specifically targets balance and gait. It performs better than standard stretching in preventing falls and decreasing neuroinflammation.
Bookimed Expert Insight: The most effective results come from combining traditional movement with advanced diagnostics. Centers like Yanda International Hospital hold Joint Commission International accreditation and use over 28,000 modern technologies. Patients benefit when specialists like Dr. Sun Chen Yang integrate ancient Qihuang medicine with Western protocols. This dual approach ensures that while Tai Chi manages symptoms, professional neurosurgical expertise addresses underlying structural issues.
Patient Consensus: Patients note that Tai Chi significantly improves stability and reduces the fear of falling. While it complements medication, they emphasize that results only appear with consistent practice at least twice weekly.
Traditional Chinese Medicine (TCM) serves as a holistic, complementary therapy for Parkinson's disease in China. Specialized clinics integrate acupuncture and herbal formulas with conventional treatments like Deep Brain Stimulation (DBS). This combined approach aims to alleviate motor symptoms, reduce medication side effects, and improve long-term sleep quality.
Bookimed Expert Insight: Bookimed data shows that leading Chinese institutions, such as Yanda International Hospital, operate at a Class A Level III status. This is the highest medical tier in China. These centers treat over 2,500,000 patients annually and emphasize multidisciplinary care. For Parkinson's, this means patients often receive care from teams led by both neurosurgeons and TCM professors. For example, Dr. Sun Chen Yang is a professor of integrative medicine and a recognized specialist in ancient Qihuang medicine. This level of integration ensures that traditional therapies like acupuncture are clinically supervised by neurological experts to maximize safety and efficacy.
Patient Consensus: Patients note that starting with acupuncture can be a low-risk way to address tremors. Many emphasize that while herbs may help reduce side effects like dyskinesia by 30% to 50%, it is crucial to monitor bloodwork with a neurologist to prevent drug interactions.
International patients can access stem cell therapy, deep brain stimulation, and MRgFUS for Parkinson's disease in China. Specialized institutions like Dr. Eber Brain Hospital and JCI-accredited Yanda International Hospital provide these advanced neurological treatments. Access typically requires an official invitation letter for medical visa support.
Bookimed Expert Insight: While many patients focus on stem cells, Bookimed data shows high demand for structured surgical interventions. A DBS procedure at Xiamen Humanity Hospital costs approximately $41,400 (300,000 CNY). This price includes 15 days of inpatient monitoring. This reflects a trend where Chinese tertiary centers bundle extended rehabilitation with high-tech surgery. It offers more comprehensive post-op care than standard outpatient models found in other regions.
Patient Consensus: Patients often find that while initial motor symptom relief is significant, long-term results vary. Many emphasize the need to arrange independent translation services as English post-operative support can be limited.